Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX.
Abstract
Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX.
참고문헌 (12)
- Borgia F, "Relapsing polychondritis : an updated review", Biomedicines, 6, pp.84~ (2018)
- Vitale A, "Relapsing polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives", Curr Rheumatol Rep, 18, pp.3~ (2016)
- Rednic S, "Relapsing polychondritis : state of the art on clinical practice guidelines", RMD Open, 4(Suppl 1), pp.e000788~ (2018)
- Michet CJ Jr, "Relapsing polychondritis : survival and predictive role of early disease manifestations", Ann Intern Med, 104, pp.74~78 (1986)
- Horvath A, "A nationwide study of the epidemiology of relapsing polychondritis", Clin Epidemiol, 8, pp.211~230 (2016)
- Orchard TR, "Peripheral arthropathies in inflammatory bowel disease : their articular distribution and natural history", Gut, 42, pp.387~391 (1998)
- Rodriguez-Reyna TS, "Rheumatic manifestations of inflammatory bowel disease", World J Gastroenterol, 15, pp.5517~5524 (2009)
- Fousekis FS, "Ear involvement in inflammatory bowel disease : a review of the literature", J Clin Med Res, 10, pp.609~614 (2018)
- Vavricka SR, "Extraintestinal manifestations of inflammatory bowel disease", Inflamm Bowel Dis, 21, pp.1982~1992 (2015)
- Mathian A, "Relapsing polychondritis: a 2016 update on clinical features, diagnostic tools, treatment and biological drug use", Best Pract Res Clin Rheumatol, 30, pp.316~333 (2016)
- Kemta Lekpa F, "Biologics in relapsing polychondritis : a literature review", Semin Arthritis Rheum, 41, pp.712~719 (2012)
- Touma DJ, "Relapsing polychondritis in association with Crohn's disease", Am J Otolaryngol, 17, pp.424~426 (1996)